This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Atkinson, J. B. Articles by Gomperts, E. Search for Related Content PubMed PubMed Citation Articles by Atkinson, J. B. Articles by Gomperts, E. Social Bookmarking                         What's this?

Investigational Use of Tissue Plasminogen Activator (t-PA) for Occluded Central Venous Catheters

Division of Pediatric Surgery and Division of Hematology//Oncology, Childrens Hospital of Los Angeles and the University of Southern California School of Medicine, Los Angeles, California

Holly A. Bagnall, R.N., M.N.

Division of Pediatric Surgery and Division of Hematology//Oncology, Childrens Hospital of Los Angeles and the University of Southern California School of Medicine, Los Angeles, California

Edward Gomperts, M.D.

Division of Pediatric Surgery and Division of Hematology//Oncology, Childrens Hospital of Los Angeles and the University of Southern California School of Medicine, Los Angeles, California

Urokinase and streptokinase are commonly used thrombolytic agents for fibrin obstructed central venous catheters. Although proven to be efficacious, these two agents have the potential to induce systemic fibrin breakdown and hemorrhage. We report our initial experience with tissue plasminogen activator (t-PA) for the treatment of occluded central venous catheters which failed urokinase. Of 25 incidents of catheter occlusion in 142 right atrial catheters, six failed to clear after an initial bolus dwell of urokinase. Five of these six catheters cleared following treatment with 2 mg/2 cc of t-PA with a mean of 1.5 bolus installations. The one catheter failure was due to catheter tip position and age of clot. No coagulation abnormalities or bleeding was observed. These data suggest that t-PA may be a safe, effective thrombolytic agent in the treatment of occluded central venous catheters. (Journal of Parenteral and Enteral Nutrition 14:310-311, 1990)

Journal of Parenteral and Enteral Nutrition, Vol. 14, No. 3, 310-311 (1990)
DOI: 10.1177/0148607190014003310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Galloway and A. Bodenham Long-term central venous access Br. J. Anaesth., May 1, 2004; 92(5): 722 - 734. [Abstract] [Full Text] [PDF]

				J. M Zacharias, C. P Weatherston, C. R Spewak, and L. M Vercaigne Alteplase Versus Urokinase for Occluded Hemodialysis Catheters Ann. Pharmacother., January 1, 2003; 37(1): 27 - 33. [Abstract] [Full Text] [PDF]

				J. P. Timoney, M. G. Malkin, D. M. Leone, J. S. Groeger, M. L. Heaney, D. L. Keefe, M. Klang, C. D. Lucarelli, R. J. Muller, S. L. Eng, et al. Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access Devices J. Clin. Oncol., April 1, 2002; 20(7): 1918 - 1922. [Abstract] [Full Text] [PDF]

				J Hartmann, A Hussein, E Trowitzsch, J Becker, and K-H Hennecke Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2001; 85(1): F18 - 22. [Abstract] [Full Text] [PDF]

				W. D. Haire and S. L. Herbst Invited Review: Use of Alteplase (t-PA) for the Management of Thrombotic Catheter Dysfunction: Guidelines From a Consensus Conference of the National Association of Vascular Access Networks (NAVAN) Nutr Clin Pract, December 1, 2000; 15(6): 265 - 275. [PDF]

				D.J. Hemphill, K.W. Sniderman, and J.P. Allard Management of Total Parenteral Nutrition-Related Superior Vena Cava Obstruction With Expandable Metal Stents JPEN J Parenter Enteral Nutr, May 1, 1996; 20(3): 222 - 227. [Abstract] [PDF]

				M. Evans and M. A. Ryder Invited Review: Vascular Access Devices: Perspectives on Designs, Complications, and Management Nutr Clin Pract, August 1, 1993; 8(4): 145 - 152. [Abstract] [PDF]

				W. D. Haire and R. P. Lieberman Thrombosed Central Venous Catheters: Restoring Function With 6-Hour Urokinase Infusion After Failure of Bolus Urokinase JPEN J Parenter Enteral Nutr, March 1, 1992; 16(2): 129 - 132. [Abstract] [PDF]

				D. Keegan-Wells and J. L. Stewart The Use of Venous Access Devices in Pediatric Oncology Nursing Practice Journal of Pediatric Oncology Nursing, January 1, 1992; 9(4): 159 - 169. [Abstract] [PDF]